Betaxolol hydrochloride 10 MG Oral Tablet — RxCUI 1297753
RxNorm drug concept · Semantic clinical drug
RxCUI 1297753
Semantic clinical drug · SCD
● Current RxNorm concept 6 FDA products
8 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1297753
Official nameBetaxolol hydrochloride 10 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbetaxolol hydrochloride 10 MG (betaxolol 8.94 MG) Oral Tablet; betaxolol HCl 10 MG Oral Tablet
FDA products mapped6
Package NDCs mapped8
Reported Medicaid activity (SDUD)469 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Betaxolol: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- That's a really common concern, and it's a good one to ask. The eye drops are absorbed into the bloodstream to some extent, but betaxolol is specifically designed to target the eye...
- I'm getting the eye drops for glaucoma — will they affect my heart or lungs like a regular beta-blocker pill would?
- Please don't stop them on your own, especially not abruptly. With betaxolol tablets, stopping suddenly — particularly if you have any coronary artery disease — can cause a rebound...
- Can I just stop taking my betaxolol tablets if I feel fine and my blood pressure seems okay?
🕸️ Concept Web — How Betaxolol hydrochloride 10 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Betaxolol hydrochloride 10 MG Oral Tablet
RxCUI 1297753 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Betaxolol
1520IN -
Betaxolol hydrochloride
142144PIN
-
Betaxolol
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Betaxolol Oral Tablet
371065SCDF -
Betaxolol hydrochloride Oral Tablet
2646569SCDFP -
Betaxolol Oral Product
1153807SCDG -
Betaxolol Pill
1153808SCDG -
Betaxolol hydrochloride Oral Product
2661965SCDGP -
Betaxolol hydrochloride Pill
2663689SCDGP -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Betaxolol Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Betaxolol hydrochloride 10 MG
1297752SCDC
-
Betaxolol hydrochloride 10 MG
Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Betaxolol hydrochloride 10 MG
SCDC · 1297752 -
Betaxolol Oral Tablet
SCDF · 371065 -
Betaxolol hydrochloride Oral Tablet
SCDFP · 2646569 -
Betaxolol Oral Product
SCDG · 1153807 -
Betaxolol Pill
SCDG · 1153808 -
Betaxolol hydrochloride Oral Product
SCDGP · 2661965 -
Betaxolol hydrochloride Pill
SCDGP · 2663689
📦 FDA Products & Package NDCs
6 products · 8 package NDCs
8 package NDCs map to RxCUI 1297753 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 10702-0013-01 | 100 TABLET, COATED in 1 BOTTLE (10702-013-01) | BETAXOLOL HYDROCHLORIDE | KVK-TECH, INC. | 2011-11-02 |
| 10702-0014-01 | 100 TABLET, COATED in 1 BOTTLE (10702-014-01) | BETAXOLOL HYDROCHLORIDE | KVK-TECH, INC. | 2011-11-02 |
| 24658-0700-01 | 100 TABLET, FILM COATED in 1 BOTTLE (24658-700-01) | Betaxolol | PuraCap Laboratories LLC | 2016-12-15 |
| 24658-0701-01 | 100 TABLET, FILM COATED in 1 BOTTLE (24658-701-01) | Betaxolol | PuraCap Laboratories LLC | 2016-12-15 |
| 42806-0038-01 | 100 TABLET, FILM COATED in 1 BOTTLE (42806-038-01) | Betaxolol | Epic Pharma LLC | 2010-07-20 |
| 42806-0038-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (42806-038-10) | Betaxolol | Epic Pharma LLC | 2010-07-20 |
| 42806-0039-01 | 100 TABLET, FILM COATED in 1 BOTTLE (42806-039-01) | Betaxolol | Epic Pharma LLC | 2010-07-20 |
| 42806-0039-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (42806-039-10) | Betaxolol | Epic Pharma LLC | 2010-07-20 |
Observed labelers:
Epic Pharma LLC (4) ·
KVK-TECH, INC. (2) ·
PuraCap Laboratories LLC (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.